Corrigendum to: A randomized, double-blind, placebo-controlled trial: The efficacy of multispecies probiotic supplementation in alleviating symptoms of irritable bowel syndrome associated with constipation (BioMed Research International (2016) 2016 (4740907) DOI: 10.1155/2016/4740907);A Randomized, Double-Blind, Placebo-Controlled Trial: The Efficacy of Multispecies Probiotic Supplementation in Alleviating Symptoms of Irritable Bowel Syndrome Associated with Constipation

BioMed Research International

Volumn 2016, Issue , 2016, Pages

  Mezzasalma, Valerio ^a   Manfrini, Enrico ^a   Ferri, Emanuele ^a   Sandionigi, Anna ^a   La Ferla, Barbara ^a   Schiano, Irene ^b   Michelotti, Angela ^b   Nobile, Vincenzo ^b   Labra, Massimo ^a   Di Gennaro, Patrizia ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b San Martino Siccomario   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PLACEBO; PROBIOTIC AGENT;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ADULT; AGED; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM ANIMALIS; BLOATING; COLONY FORMING UNIT; CONSTIPATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; FECES ANALYSIS; FEMALE; FLATULENCE; FOLLOW UP; GASTROINTESTINAL DISEASE; HUMAN; INTESTINE FLORA; IRRITABLE COLON; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PLANTARUM; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MIDDLE AGED; POLYMERASE CHAIN REACTION; RANDOMIZED CONTROLLED TRIAL; SPECIES DIFFERENCE; SYMPTOM; ADOLESCENT; COMPLICATION; DIETARY SUPPLEMENT; IRRITABLE BOWEL SYNDROME; MICROBIOLOGY;

ADOLESCENT; ADULT; AGED; CONSTIPATION; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PROBIOTICS;

EID: 84984692528     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2019/9042956     Document Type: Erratum

References (30)

1. P. B. Eckburg, E. M. Bik, C. N. Bernstein et al., "Microbiology: diversity of the human intestinal microbial flora, " Science, vol. 308, no. 5728, pp. 1635-1638, 2005.
2. S. K. Mazmanian, H. L. Cui, A. O. Tzianabos, and D. L. Kasper, "An immunomodulatorymolecule of symbiotic bacteria directs maturation of the host immune system, " Cell, vol. 122, no. 1, pp. 107-118, 2005.
3. V. R. Alonso and F. Guarner, "Linking the gut microbiota to human health, " British Journal of Nutrition, vol. 109, supplement 2, pp. S21-S26, 2013.
4. G. Tomasello, M. Bellavia, V. D. Palumbo, M. C. Gioviale, P. Damiani, and A. I. L. Monte, "From gut microflora imbalance to mycobacteria infection: is there a relationship with chronic intestinal inflammatory diseases" Annali Italiani di Chirurgia, vol. 82, no. 5, pp. 361-368, 2011.
5. F. Guarner and J.-R. Malagelada, "Gut flora in health and disease, " The Lancet, vol. 361, no. 9356, pp. 512-519, 2003.
6. J. Mättö, L. Maunuksela, K. Kajander et al., "Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome- A longitudinal study in IBS and control subjects, " FEMS Immunology andMedicalMicrobiology, vol. 43, no. 2, pp. 213-222, 2005.
7. C. Abraham and J. H. Cho, "Mechanisms of disease: inflammatory bowel disease, " The New England Journal of Medicine, vol. 361, no. 21, pp. 2066-2078, 2009.
8. M. Bellavia, G. Damiano, M. C. Gioviale et al., "Abnormal expansion of segmented filamentous bacteria in the gut: a role in pathogenesis of chronic inflammatory intestinal diseases" Reviews in Medical Microbiology, vol. 22, no. 3, pp. 45-47, 2011.
9. M. Bellavia, G. Tomasello, M. Romeo et al., "Gut microbiota imbalance and chaperoning system malfunction are central to ulcerative colitis pathogenesis and can be counteracted with specifically designed probiotics: a working hypothesis, " Medical Microbiology and Immunology, vol. 202, no. 6, pp. 393-406, 2013.
10. W. Strober, I. Fuss, and P. Mannon, "The fundamental basis of inflammatory bowel disease, " Journal of Clinical Investigation, vol. 117, no. 3, pp. 514-521, 2007.
11. M. Llopis, M. Antolin, M. Carol et al., "Lactobacillus casei downregulates commensals' inflammatory signals in Crohn's diseasemucosa, " Inflammatory Bowel Diseases, vol. 15, no. 2, pp. 275-283, 2009.
12. M. Pammi, A. Flores, M. Leeflang, and J. Versalovic, "Molecular assays in the diagnosis of neonatal sepsis: a systematic review and meta-analysis, " Pediatrics, vol. 128, no. 4, pp. e973-e985, 2011.
13. M. Venkatesh, A. Flores, R. A. Luna, and J. Versalovic, "Molecular microbiological methods in the diagnosis of neonatal sepsis, " Expert Review of Anti-Infective Therapy, vol. 8, no. 9, pp. 1037-1048, 2010.
14. K. Kajander, E. Myllyluoma, M. Rajilíc-Stojanovíc et al., "Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota, "Alimentary Pharmacology andTherapeutics, vol. 27, no. 1, pp. 48-57, 2008.
15. J. S. Yoon, W. Sohn, O. Y. Lee et al., "Effect of multispecies probiotics on irritable bowel syndrome: a randomized, doubleblind, placebo-controlled trial, " Journal of Gastroenterology and Hepatology, vol. 29, no. 1, pp. 52-59, 2014.
16. A. P. S. Hungin, C. Mulligan, B. Pot et al., "Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice-an evidence-based international guide, " Alimentary Pharmacology andTherapeutics, vol. 38, no. 8, pp. 864-886, 2013.
17. A. Agrawal, L. A. Houghton, J. Morris et al., "Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation, " Alimentary Pharmacology andTherapeutics, vol. 29, no. 1, pp. 104-114, 2009.
18. S. Guglielmetti, D. Mora, M. Gschwender, and K. Popp, "Randomised clinical trial: Bifidobacteriumbifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life- A double-blind, Placebo-Controlled Study, " Alimentary Pharmacology and Therapeutics, vol. 33, no. 10, pp. 1123-1132, 2011.
19. I. Presti, G. D'Orazio, M. Labra et al., "Evaluation of the probiotic properties of new Lactobacillus and Bifidobacterium strains and their in vitro effect, " Applied Microbiology and Biotechnology, vol. 99, no. 13, pp. 5613-5626, 2015.
20. I. Aloisio, C. Santini, B. Biavati et al., "Characterization of Bifidobacterium spp. strains for the treatment of enteric disorders in newborns, " Applied Microbiology and Biotechnology, vol. 96, no. 6, pp. 1561-1576, 2012.
21. D. A. Drossman, E. Corazziari, M. Delvaux et al., Eds., Rome III: The Functional Gastrointestinal Disorders, Degnon Associates, McLean, Va, USA, 3rd edition, 2006.
22. D. L. Patrick, D. A. Drossman, I. O. Frederick, J. Dicesare, and K. L. Puder, "Quality of life in persons with irritable bowel syndrome: development and validation of a new measure, " Digestive Diseases and Sciences, vol. 43, no. 2, pp. 400-411, 1998.
23. S. J. Lewis and K. W. Heaton, "Stool form scale as a useful guide to intestinal transit time, " Scandinavian Journal of Gastroenterology, vol. 32, no. 9, pp. 920-924, 1997.
24. M. Enrico, Biological sciences [Ph. D. thesis], The University of Milano-Bicocca, 2015.
25. M. V. Matz, R. M. Wright, and J. G. Scott, "No control genes required: Bayesian analysis of qRT-PCR data, " PloS ONE, vol. 8, no. 8, Article IDe71448, 2013.
26. H. Wickham, ggplot2: Elegant Graphics for Data Analysis, Springer Science & BusinessMedia, Springer-Verlag, New York, NY, USA, 2009.
27. J. Plaza-Diaz, C. Gomez-Llorente, L. Fontana, and A. Gil, "Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics, "World Journal of Gastroenterology, vol. 20, no. 42, pp. 15632-15649, 2014.
28. A. P. M. Kerckhoffs, M. Samsom, M. E. van der Rest et al., "Lower Bifidobacteria counts in both duodenal mucosaassociated and fecal microbiota in irritable bowel syndrome patients, " World Journal of Gastroenterology, vol. 15, no. 23, pp. 2887-2892, 2009.
29. E. Malinen, T. Rinttilä, K. Kajander et al., "Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR, " American Journal of Gastroenterology, vol. 100, no. 2, pp. 373-382, 2005.
30. P. Moayyedi, A. C. Ford, N. J. Talley et al., "The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review, " Gut, vol. 59, no. 3, pp. 325-332, 2010.